Animal Vaccines Market Size, Share & Trends Analysis Report By Animal Type (Livestock, Companion), By Product (Attenuated Live Vaccines, Recombinant Vaccines), By Route Of Administration, By Distribution Channel, By Region, And Segment Forecasts, 2024 - 2030
This report can be delivered to the clients within 3 Business Days
Vacuum Insulation Panel Market Growth & Trends
The global vacuum insulation panel market size is anticipated to reach USD 10.82 billion by 2030, according to a new report by Grand View Research, Inc. The market is projected to grow at a CAGR of 4.3% from 2024 to 2030. Growing construction spending is expected to assist the growth for vacuum insulation panel over the forecast period. These are preferred more, owing to their thermal resistance properties compared to conventional insulation materials.
Moreover, the International Energy Agency issued strict regulations to conserve energy which has further propelled the demand for such panels. These panels help in reducing greenhouse gas emissions such as carbon dioxide from the atmosphere, thus helping to prevent polluting the environment to a large extent. Such a trend is anticipated to benefit the overall market over the next eight years.
However, vacuum insulation panels exhibit a heavier weight than conventional insulation materials which is expected to remain a key challenge for market participants. Factors such as, durability, shape and fragility are also anticipated to determine the demand for vacuum insulation panels in future.
Several R&D initiatives are being taken to introduce automated panels, which shall result in cost reduction of vacuum insulation panels over the forecast period. Recently, EVAL EVOH resins are added to provide an outer lamination coating for vacuum insulation panels to increase their shelf life.
Vacuum Insulation Panel Market Report Highlights
Vacuum Insulation Panel Market Growth & Trends
The global vacuum insulation panel market size is anticipated to reach USD 10.82 billion by 2030, according to a new report by Grand View Research, Inc. The market is projected to grow at a CAGR of 4.3% from 2024 to 2030. Growing construction spending is expected to assist the growth for vacuum insulation panel over the forecast period. These are preferred more, owing to their thermal resistance properties compared to conventional insulation materials.
Moreover, the International Energy Agency issued strict regulations to conserve energy which has further propelled the demand for such panels. These panels help in reducing greenhouse gas emissions such as carbon dioxide from the atmosphere, thus helping to prevent polluting the environment to a large extent. Such a trend is anticipated to benefit the overall market over the next eight years.
However, vacuum insulation panels exhibit a heavier weight than conventional insulation materials which is expected to remain a key challenge for market participants. Factors such as, durability, shape and fragility are also anticipated to determine the demand for vacuum insulation panels in future.
Several R&D initiatives are being taken to introduce automated panels, which shall result in cost reduction of vacuum insulation panels over the forecast period. Recently, EVAL EVOH resins are added to provide an outer lamination coating for vacuum insulation panels to increase their shelf life.
Vacuum Insulation Panel Market Report Highlights
- The silica segment dominated the market with 45.2% of revenue share in 2023. This is due to their exceptional thermal insulation properties.
- The flat segment dominated the market with 55.1% of revenue share in 2023. This is due to their ease of manufacturing, handling, and installation.
- The metals segment accounted for the largest market revenue share in 2023. This is due to their excellent barrier properties, thermal conductivity properties and recyclability.
- Construction accounted for the largest market with a revenue share of 61.5% in 2023. The increasing demand for energy-efficient building materials is a significant factor driving the growth of VIPs in the construction sector.
- The North America vacuum insulation panel market is anticipated to grow at a CAGR of 4.1% during the forecast period.
CHAPTER 1. METHODOLOGY AND SCOPE
1.1. Market Segmentation and Scope
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased Database
1.3.2. GVR’s Internal Database
1.3.3. Secondary Sources
1.3.4. Primary Research
1.4. Information/Data Analysis
1.5. Market Formulation & Visualization
1.6. Data Validation & Publishing
1.7. Model Details
1.7.1. Commodity flow analysis
1.7.2. Global Market: CAGR Calculation
1.8. List of Secondary Sources
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
CHAPTER 3. ANIMAL VACCINES MARKET VARIABLE TRENDS & SCOPE
3.1. Market Lineage Outlook
3.1.1. Parent Market
3.1.2. Ancillary Market
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Rising livestock population
3.2.1.2. Increasing disease outbreak
3.2.1.3. Rising R&D and manufacturing advancements
3.2.1.4. Growing demand for animal derived food products
3.2.2. Market Restraint Analysis
3.2.2.1. Lack of awareness
3.2.2.2. High cost of care
3.2.3. Market Opportunity Analysis
3.2.4. Market Challenge Analysis
3.3. Animal Vaccines Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Bargaining power of suppliers
3.3.1.2. Bargaining power of buyers
3.3.1.3. Threat of substitution
3.3.1.4. Threat of new entrants
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political & Legal landscape
3.3.2.2. Economic and Social landscape
3.3.2.3. Technological landscape
3.3.2.4. Environmental landscape
3.3.3. Regulatory Framework
3.3.4. Pricing Analysis
3.3.5. Estimated Animal Population by key countries, key species, 2023
3.3.6. COVID-19 Impact Analysis
CHAPTER 4. ANIMAL VACCINES MARKET: ANIMAL TYPE ESTIMATES & TREND ANALYSIS
4.1. Segment Dashboard
4.2. Animal Vaccines Market: Animal type Movement Analysis
4.3. Animal Vaccines Market Size & Trend Analysis, by animal type, 2018 to 2030 (USD Million)
4.4. Livestock
4.4.1. Livestock Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4.2. Poultry
4.4.2.1. Poultry Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4.3. Aqua
4.4.3.1. Aqua Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4.4. Ruminant
4.4.4.1. Ruminant Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4.5. Swine
4.4.5.1. Swine Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5. Companion
4.5.1. Companion Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5.2. Canine
4.5.2.1. Canine Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5.3. Feline
4.5.3.1. Feline Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5.4. Others
4.5.4.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
CHAPTER 5. ANIMAL VACCINES MARKET: BY PRODUCT ESTIMATES & TREND ANALYSIS
5.1. Segment Dashboard
5.2. Animal Vaccines Market: By Product Movement Analysis
5.3. Animal Vaccines Market Size & Trend Analysis, by product, 2018 to 2030 (USD Million)
5.3.1. Attenuated Live Vaccines
5.3.1.1. Attenuated Live Vaccines Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.3.2. Inactivated Vaccines
5.3.2.1. Inactivated Vaccines Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.3.3. Subunit Vaccines
5.3.3.1. Subunit Vaccines Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.3.4. DNA Vaccines
5.3.4.1. DNA Vaccines Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.3.5. Recombinant Vaccines
5.3.5.1. Recombinant Vaccines Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
CHAPTER 6. ANIMAL VACCINES MARKET: BY ROUTE OF ADMINISTRATION ESTIMATES & TREND ANALYSIS
6.1. Segment Dashboard
6.2. Animal Vaccines Market: By Route of Administration Movement Analysis
6.3. Animal Vaccines Market Size & Trend Analysis, by route of administration, 2018 to 2030 (USD Million)
6.3.1. Subcutaneous
6.3.1.1. Subcutaneous Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3.2. Intramuscular
6.3.2.1. Intramuscular Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3.3. Intranasal
6.3.3.1. Intranasal Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
CHAPTER 7. ANIMAL VACCINES MARKET: BY DISTRIBUTION CHANNEL ESTIMATES & TREND ANALYSIS
7.1. Segment Dashboard
7.2. Animal Vaccines Market: By Distribution Channel Movement Analysis
7.3. Animal Vaccines Market Size & Trend Analysis, by distribution channel, 2018 to 2030 (USD Million)
7.3.1. Retail
7.3.1.1. Retail Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.2. E-Commerce
7.3.2.1. E-Commerce Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.3. Hospital/Clinic Pharmacy
7.3.3.1. Hospital/Clinic Pharmacy Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
CHAPTER 8. ANIMAL VACCINES MARKET: REGIONAL ESTIMATES & TREND ANALYSIS
8.1. Regional Dashboard
8.2. Animal Vaccines Market Share, By Region, 2023 & 2030 (USD Million)
8.3. Regional Outlook
8.4. North America
8.4.1. North America Animal Vaccines Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.4.2. U.S.
8.4.2.1. Key Country Dynamics
8.4.2.2. U.S. Animal Vaccines Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.4.3. Canada
8.4.3.1. Key Country Dynamics
8.4.3.2. Canada Animal Vaccines Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.4.4. Mexico
8.4.4.1. Key Country Dynamics
8.4.4.2. Mexico Animal Vaccines Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.5. Europe
8.5.1. Europe Animal Vaccines Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.5.2. UK
8.5.2.1. Key Country Dynamics
8.5.2.2. UK Animal Vaccines Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.5.3. Germany
8.5.3.1. Key Country Dynamics
8.5.3.2. Germany Animal Vaccines Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.5.4. France
8.5.4.1. Key Country Dynamics
8.5.4.2. France Animal Vaccines Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.5.5. Italy
8.5.5.1. Key Country Dynamics
8.5.5.2. Italy Animal Vaccines Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.5.6. Spain
8.5.6.1. Key Country Dynamics
8.5.6.2. Spain Animal Vaccines Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.5.7. Denmark
8.5.7.1. Key Country Dynamics
8.5.7.2. Denmark Animal Vaccines Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.5.8. Sweden
8.5.8.1. Key Country Dynamics
8.5.8.2. Sweden Animal Vaccines Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.5.9. Norway
8.5.9.1. Key Country Dynamics
8.5.9.2. Norway Animal Vaccines Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.6. Asia Pacific
8.6.1. Asia Pacific Animal Vaccines Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.6.2. Japan
8.6.2.1. Key Country Dynamics
8.6.2.2. Japan Animal Vaccines Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.6.3. China
8.6.3.1. Key Country Dynamics
8.6.3.2. China Animal Vaccines Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.6.4. India
8.6.4.1. Key Country Dynamics
8.6.4.2. India Animal Vaccines Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.6.5. Australia
8.6.5.1. Key Country Dynamics
8.6.5.2. Australia Animal Vaccines Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.6.6. South Korea
8.6.6.1. Key Country Dynamics
8.6.6.2. South Korea Animal Vaccines Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.6.7. Thailand
8.6.7.1. Key Country Dynamics
8.6.7.2. Thailand Animal Vaccines Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.7. Latin America
8.7.1. Latin America Animal Vaccines Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.7.2. Brazil
8.7.2.1. Key Country Dynamics
8.7.2.2. Brazil Animal Vaccines Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.7.3. Argentina
8.7.3.1. Key Country Dynamics
8.7.3.2. Argentina Animal Vaccines Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.8. Middle East & Africa
8.8.1. Middle East & Africa Animal Vaccines Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.8.2. South Africa
8.8.2.1. Key Country Dynamics
8.8.2.2. South Africa Animal Vaccines Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.8.3. Saudi Arabia
8.8.3.1. Key Country Dynamics
8.8.3.2. Saudi Arabia Animal Vaccines Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.8.4. UAE
8.8.4.1. Key Country Dynamics
8.8.4.2. UAE Animal Vaccines Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.8.5. Kuwait
8.8.5.1. Key Country Dynamics
8.8.5.2. Kuwait Animal Vaccines Market Estimates And Forecasts, 2018 - 2030 (USD Million)
CHAPTER 9. COMPETITIVE LANDSCAPE
9.1. Market Participant Categorization
9.2. Company Market Position Analysis/ Heap Map Analysis
9.3. Company Profiles
9.3.1. Merck & Co., Inc.
9.3.1.1. Participant’s Overview
9.3.1.2. Financial Performance
9.3.1.3. Product Benchmarking
9.3.1.4. Strategic Initiatives
9.3.2. Zoetis
9.3.2.1. Participant’s Overview
9.3.2.2. Financial Performance
9.3.2.3. Product Benchmarking
9.3.2.4. Strategic Initiatives
9.3.3. Virbac
9.3.3.1. Participant’s Overview
9.3.3.2. Financial Performance
9.3.3.3. Product Benchmarking
9.3.3.4. Strategic Initiatives
9.3.4. Elanco
9.3.4.1. Participant’s Overview
9.3.4.2. Financial Performance
9.3.4.3. Product Benchmarking
9.3.4.4. Strategic Initiatives
9.3.5. Boehringer Ingelheim Animal Health
9.3.5.1. Participant’s Overview
9.3.5.2. Financial Performance
9.3.5.3. Product Benchmarking
9.3.5.4. Strategic Initiatives
9.3.6. Phibro Animal Health Corporation
9.3.6.1. Participant’s Overview
9.3.6.2. Financial Performance
9.3.6.3. Product Benchmarking
9.3.6.4. Strategic Initiatives
9.3.7. Calier
9.3.7.1. Participant’s Overview
9.3.7.2. Financial Performance
9.3.7.3. Product Benchmarking
9.3.7.4. Strategic Initiatives
9.3.8. Ceva
9.3.8.1. Participant’s Overview
9.3.8.2. Financial Performance
9.3.8.3. Product Benchmarking
9.3.8.4. Strategic Initiatives
9.3.9. Bimeda Biologicals
9.3.9.1. Participant’s Overview
9.3.9.2. Financial Performance
9.3.9.3. Product Benchmarking
9.3.9.4. Strategic Initiatives
9.3.10. Neogen Corporation
9.3.10.1. Participant’s Overview
9.3.10.2. Financial Performance
9.3.10.3. Product Benchmarking
9.3.10.4. Strategic Initiatives
9.4. Strategy Mapping
9.4.1. Mergers & Acquisitions
9.4.2. Partnerships & Collaborations
9.4.3. Expansion
9.4.4. Product launch
9.4.5. Product Approval
9.4.6. Others
9.5. List of other key players
1.1. Market Segmentation and Scope
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased Database
1.3.2. GVR’s Internal Database
1.3.3. Secondary Sources
1.3.4. Primary Research
1.4. Information/Data Analysis
1.5. Market Formulation & Visualization
1.6. Data Validation & Publishing
1.7. Model Details
1.7.1. Commodity flow analysis
1.7.2. Global Market: CAGR Calculation
1.8. List of Secondary Sources
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
CHAPTER 3. ANIMAL VACCINES MARKET VARIABLE TRENDS & SCOPE
3.1. Market Lineage Outlook
3.1.1. Parent Market
3.1.2. Ancillary Market
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Rising livestock population
3.2.1.2. Increasing disease outbreak
3.2.1.3. Rising R&D and manufacturing advancements
3.2.1.4. Growing demand for animal derived food products
3.2.2. Market Restraint Analysis
3.2.2.1. Lack of awareness
3.2.2.2. High cost of care
3.2.3. Market Opportunity Analysis
3.2.4. Market Challenge Analysis
3.3. Animal Vaccines Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Bargaining power of suppliers
3.3.1.2. Bargaining power of buyers
3.3.1.3. Threat of substitution
3.3.1.4. Threat of new entrants
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political & Legal landscape
3.3.2.2. Economic and Social landscape
3.3.2.3. Technological landscape
3.3.2.4. Environmental landscape
3.3.3. Regulatory Framework
3.3.4. Pricing Analysis
3.3.5. Estimated Animal Population by key countries, key species, 2023
3.3.6. COVID-19 Impact Analysis
CHAPTER 4. ANIMAL VACCINES MARKET: ANIMAL TYPE ESTIMATES & TREND ANALYSIS
4.1. Segment Dashboard
4.2. Animal Vaccines Market: Animal type Movement Analysis
4.3. Animal Vaccines Market Size & Trend Analysis, by animal type, 2018 to 2030 (USD Million)
4.4. Livestock
4.4.1. Livestock Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4.2. Poultry
4.4.2.1. Poultry Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4.3. Aqua
4.4.3.1. Aqua Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4.4. Ruminant
4.4.4.1. Ruminant Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4.5. Swine
4.4.5.1. Swine Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5. Companion
4.5.1. Companion Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5.2. Canine
4.5.2.1. Canine Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5.3. Feline
4.5.3.1. Feline Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5.4. Others
4.5.4.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
CHAPTER 5. ANIMAL VACCINES MARKET: BY PRODUCT ESTIMATES & TREND ANALYSIS
5.1. Segment Dashboard
5.2. Animal Vaccines Market: By Product Movement Analysis
5.3. Animal Vaccines Market Size & Trend Analysis, by product, 2018 to 2030 (USD Million)
5.3.1. Attenuated Live Vaccines
5.3.1.1. Attenuated Live Vaccines Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.3.2. Inactivated Vaccines
5.3.2.1. Inactivated Vaccines Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.3.3. Subunit Vaccines
5.3.3.1. Subunit Vaccines Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.3.4. DNA Vaccines
5.3.4.1. DNA Vaccines Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.3.5. Recombinant Vaccines
5.3.5.1. Recombinant Vaccines Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
CHAPTER 6. ANIMAL VACCINES MARKET: BY ROUTE OF ADMINISTRATION ESTIMATES & TREND ANALYSIS
6.1. Segment Dashboard
6.2. Animal Vaccines Market: By Route of Administration Movement Analysis
6.3. Animal Vaccines Market Size & Trend Analysis, by route of administration, 2018 to 2030 (USD Million)
6.3.1. Subcutaneous
6.3.1.1. Subcutaneous Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3.2. Intramuscular
6.3.2.1. Intramuscular Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3.3. Intranasal
6.3.3.1. Intranasal Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
CHAPTER 7. ANIMAL VACCINES MARKET: BY DISTRIBUTION CHANNEL ESTIMATES & TREND ANALYSIS
7.1. Segment Dashboard
7.2. Animal Vaccines Market: By Distribution Channel Movement Analysis
7.3. Animal Vaccines Market Size & Trend Analysis, by distribution channel, 2018 to 2030 (USD Million)
7.3.1. Retail
7.3.1.1. Retail Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.2. E-Commerce
7.3.2.1. E-Commerce Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.3. Hospital/Clinic Pharmacy
7.3.3.1. Hospital/Clinic Pharmacy Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
CHAPTER 8. ANIMAL VACCINES MARKET: REGIONAL ESTIMATES & TREND ANALYSIS
8.1. Regional Dashboard
8.2. Animal Vaccines Market Share, By Region, 2023 & 2030 (USD Million)
8.3. Regional Outlook
8.4. North America
8.4.1. North America Animal Vaccines Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.4.2. U.S.
8.4.2.1. Key Country Dynamics
8.4.2.2. U.S. Animal Vaccines Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.4.3. Canada
8.4.3.1. Key Country Dynamics
8.4.3.2. Canada Animal Vaccines Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.4.4. Mexico
8.4.4.1. Key Country Dynamics
8.4.4.2. Mexico Animal Vaccines Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.5. Europe
8.5.1. Europe Animal Vaccines Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.5.2. UK
8.5.2.1. Key Country Dynamics
8.5.2.2. UK Animal Vaccines Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.5.3. Germany
8.5.3.1. Key Country Dynamics
8.5.3.2. Germany Animal Vaccines Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.5.4. France
8.5.4.1. Key Country Dynamics
8.5.4.2. France Animal Vaccines Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.5.5. Italy
8.5.5.1. Key Country Dynamics
8.5.5.2. Italy Animal Vaccines Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.5.6. Spain
8.5.6.1. Key Country Dynamics
8.5.6.2. Spain Animal Vaccines Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.5.7. Denmark
8.5.7.1. Key Country Dynamics
8.5.7.2. Denmark Animal Vaccines Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.5.8. Sweden
8.5.8.1. Key Country Dynamics
8.5.8.2. Sweden Animal Vaccines Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.5.9. Norway
8.5.9.1. Key Country Dynamics
8.5.9.2. Norway Animal Vaccines Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.6. Asia Pacific
8.6.1. Asia Pacific Animal Vaccines Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.6.2. Japan
8.6.2.1. Key Country Dynamics
8.6.2.2. Japan Animal Vaccines Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.6.3. China
8.6.3.1. Key Country Dynamics
8.6.3.2. China Animal Vaccines Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.6.4. India
8.6.4.1. Key Country Dynamics
8.6.4.2. India Animal Vaccines Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.6.5. Australia
8.6.5.1. Key Country Dynamics
8.6.5.2. Australia Animal Vaccines Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.6.6. South Korea
8.6.6.1. Key Country Dynamics
8.6.6.2. South Korea Animal Vaccines Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.6.7. Thailand
8.6.7.1. Key Country Dynamics
8.6.7.2. Thailand Animal Vaccines Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.7. Latin America
8.7.1. Latin America Animal Vaccines Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.7.2. Brazil
8.7.2.1. Key Country Dynamics
8.7.2.2. Brazil Animal Vaccines Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.7.3. Argentina
8.7.3.1. Key Country Dynamics
8.7.3.2. Argentina Animal Vaccines Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.8. Middle East & Africa
8.8.1. Middle East & Africa Animal Vaccines Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.8.2. South Africa
8.8.2.1. Key Country Dynamics
8.8.2.2. South Africa Animal Vaccines Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.8.3. Saudi Arabia
8.8.3.1. Key Country Dynamics
8.8.3.2. Saudi Arabia Animal Vaccines Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.8.4. UAE
8.8.4.1. Key Country Dynamics
8.8.4.2. UAE Animal Vaccines Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.8.5. Kuwait
8.8.5.1. Key Country Dynamics
8.8.5.2. Kuwait Animal Vaccines Market Estimates And Forecasts, 2018 - 2030 (USD Million)
CHAPTER 9. COMPETITIVE LANDSCAPE
9.1. Market Participant Categorization
9.2. Company Market Position Analysis/ Heap Map Analysis
9.3. Company Profiles
9.3.1. Merck & Co., Inc.
9.3.1.1. Participant’s Overview
9.3.1.2. Financial Performance
9.3.1.3. Product Benchmarking
9.3.1.4. Strategic Initiatives
9.3.2. Zoetis
9.3.2.1. Participant’s Overview
9.3.2.2. Financial Performance
9.3.2.3. Product Benchmarking
9.3.2.4. Strategic Initiatives
9.3.3. Virbac
9.3.3.1. Participant’s Overview
9.3.3.2. Financial Performance
9.3.3.3. Product Benchmarking
9.3.3.4. Strategic Initiatives
9.3.4. Elanco
9.3.4.1. Participant’s Overview
9.3.4.2. Financial Performance
9.3.4.3. Product Benchmarking
9.3.4.4. Strategic Initiatives
9.3.5. Boehringer Ingelheim Animal Health
9.3.5.1. Participant’s Overview
9.3.5.2. Financial Performance
9.3.5.3. Product Benchmarking
9.3.5.4. Strategic Initiatives
9.3.6. Phibro Animal Health Corporation
9.3.6.1. Participant’s Overview
9.3.6.2. Financial Performance
9.3.6.3. Product Benchmarking
9.3.6.4. Strategic Initiatives
9.3.7. Calier
9.3.7.1. Participant’s Overview
9.3.7.2. Financial Performance
9.3.7.3. Product Benchmarking
9.3.7.4. Strategic Initiatives
9.3.8. Ceva
9.3.8.1. Participant’s Overview
9.3.8.2. Financial Performance
9.3.8.3. Product Benchmarking
9.3.8.4. Strategic Initiatives
9.3.9. Bimeda Biologicals
9.3.9.1. Participant’s Overview
9.3.9.2. Financial Performance
9.3.9.3. Product Benchmarking
9.3.9.4. Strategic Initiatives
9.3.10. Neogen Corporation
9.3.10.1. Participant’s Overview
9.3.10.2. Financial Performance
9.3.10.3. Product Benchmarking
9.3.10.4. Strategic Initiatives
9.4. Strategy Mapping
9.4.1. Mergers & Acquisitions
9.4.2. Partnerships & Collaborations
9.4.3. Expansion
9.4.4. Product launch
9.4.5. Product Approval
9.4.6. Others
9.5. List of other key players
